Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia M Roblin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|March 26, 2003
In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniaePatricia M Roblin, Margaret R Hammerschlag
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection modelAndrei Kutlin, Patricia M Roblin, Margaret R Hammerschlag
Antimicrobial Agents and Chemotherapy|January 18, 2002
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection ModelAndrei Kutlin, Patricia M Roblin, Margaret R Hammerschlag
International Journal of Antimicrobial Agents|June 7, 2003
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniaePatricia M Roblin, Tamara Reznik, Margaret R Hammerschlag
Prehospital and Disaster Medicine|January 30, 2013
Addressing the gaps in preparation for quarantineRita Nathawad, Patricia M Roblin, Darrin Pruitt, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaePatricia M Roblin, Tamara Reznik, Andrei Kutlin, et al.
American Journal of Disaster Medicine|June 16, 2009
Lessons from the "Clean Baby 2007" pediatric decontamination drillBaruch S Fertel, Stephan A Kohlhoff, Patricia M Roblin, et al.
Prehospital and Disaster Medicine|July 29, 2014
Impact of Hurricane Sandy on hospital emergency and dialysis services: a retrospective surveyChou-Jui Lin, Lauren C Pierce, Patricia M Roblin, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2009
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniaePatricia M Roblin, Stephan A Kohlhoff, Charles Parker, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaeSheila Malay, Patricia M Roblin, Tamara Reznik, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|March 26, 2003
In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniaePatricia M Roblin, Margaret R Hammerschlag
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection modelAndrei Kutlin, Patricia M Roblin, Margaret R Hammerschlag
Antimicrobial Agents and Chemotherapy|January 18, 2002
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection ModelAndrei Kutlin, Patricia M Roblin, Margaret R Hammerschlag
International Journal of Antimicrobial Agents|June 7, 2003
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniaePatricia M Roblin, Tamara Reznik, Margaret R Hammerschlag
Prehospital and Disaster Medicine|January 30, 2013
Addressing the gaps in preparation for quarantineRita Nathawad, Patricia M Roblin, Darrin Pruitt, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaePatricia M Roblin, Tamara Reznik, Andrei Kutlin, et al.
American Journal of Disaster Medicine|June 16, 2009
Lessons from the "Clean Baby 2007" pediatric decontamination drillBaruch S Fertel, Stephan A Kohlhoff, Patricia M Roblin, et al.
Prehospital and Disaster Medicine|July 29, 2014
Impact of Hurricane Sandy on hospital emergency and dialysis services: a retrospective surveyChou-Jui Lin, Lauren C Pierce, Patricia M Roblin, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2009
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniaePatricia M Roblin, Stephan A Kohlhoff, Charles Parker, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaeSheila Malay, Patricia M Roblin, Tamara Reznik, et al.
Pageof 2